BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guillen A, Finotello R, Wynne P, Harper A, Killick D, Amores-Fuster I, Blackwood L. Toxicity of cytarabine constant rate infusion in dogs with high-grade non-Hodgkin lymphoma with bone marrow or central nervous system involvement. Aust Vet J 2020;98:69-78. [PMID: 31769013 DOI: 10.1111/avj.12895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Chavalle T, Chamel G, Denoeux P, Lajoinie M, Sayag D, Berny P, Ponce F. Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs. Vet Comp Oncol 2021. [PMID: 34775666 DOI: 10.1111/vco.12782] [Reference Citation Analysis]
2 Zilli J, Olszewska A, Farke D, Schmidt MJ. Successful surgical and medical treatment of a severe, acute epidural bleed in a young dog due to steroid responsive meningitis-arteritis. Acta Vet Scand 2021;63:27. [PMID: 34246290 DOI: 10.1186/s13028-021-00593-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stee K, Broeckx BJG, Targett M, Gomes SA, Lowrie M. Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin. Vet Rec 2020;187:e98. [PMID: 32862133 DOI: 10.1136/vr.106019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]